Stiris Research Inc

Call Directions Website Contact the business

Stiris Research Inc Stiris is an Clinical Trial Management company providing Phase I to IIIB full-service support to Biotechnology & Biopharmaceutical companies.

Stiris Research Inc manages Phase I through Phase IV Clinical Trials for Pharmaceutical, Biotechnology and Medical Device Companies.

Meaningful conversations. Stronger connections. Better clinical research.Stiris Research is proud to sponsor  – The Clin...
2026-11-12

Meaningful conversations. Stronger connections. Better clinical research.

Stiris Research is proud to sponsor – The Clinical Roundtable Network, taking place on November 19 in Somerville, MA.

Our President & CEO, Shantal Feltham, will join pharmaceutical and biotechnology leaders to exchange perspectives, address shared challenges, and explore new approaches to clinical trial ex*****on.

We believe meaningful progress in clinical research begins with collaboration, shared knowledge, and open dialogue. We're proud to support a forum that brings these principles together.

Studies can recover. When a   starts going off track, the answer isn’t always to start over. Sometimes it takes the righ...
2026-11-03

Studies can recover.

When a starts going off track, the answer isn’t always to start over.

Sometimes it takes the right expertise. Sometimes it means changing how one part of the study is managed. Other times, a broader transition is needed.

What stays constant is understanding the problem, taking ownership, and building an approach around the study and the sponsor.

When a one-size-fits-all becomes one-size-fits-none. That’s why we start with what your study needs.

Swipe to see three rescue case studies, and find more on our website.

If your study isn’t where it needs to be, let’s talk about getting it back on track.

A complex study is falling behind. The same issues keep coming back. Confidence is slipping. The instinct is to start ov...
2026-10-28

A complex study is falling behind. The same issues keep coming back. Confidence is slipping.

The instinct is to start over. But that might not be what the study needs right now.

Rescue starts with honest questions. What’s actually causing the delays? Who owns the next decision? What can be fixed without losing the progress you’ve already made?

The answers look different every time. Sometimes it’s added oversight, with key project members working alongside your current team. Sometimes it’s taking over the one function that isn’t working. And sometimes a full transition really is the right call. We’ll give you an honest read on which one fits.

At Stiris Research, we build the plan around the needs of the sponsor and the study.

When a study starts slipping, what’s the first thing you look at: the process, the people, or the plan? Tell us in the comments, or message us if you’d rather talk it through.

First patient in. Sites activated. Everyone's celebrating. Months later, the sponsor chases updates, escalates issues, a...
2026-10-22

First patient in. Sites activated. Everyone's celebrating.

Months later, the sponsor chases updates, escalates issues, and solves problems the was hired to own.

Nobody planned for that. It happened one small delay at a time.

Madison Pearce, Clinical Project Manager, explores how these operational challenges can quietly shift responsibilities onto sponsors, and why adding more resources isn't always the answer.

Read the full article: https://stirisresearch.com/press-releases/when-one-size-fits-all-becomes-one-size-fits-none/

Advancing   research takes more than scientific innovation. It takes meaningful partnerships.We execute rare disease stu...
2026-10-20

Advancing research takes more than scientific innovation. It takes meaningful partnerships.

We execute rare disease studies with patients, families, and sites in mind from day one. Moving research forward requires experienced teams, shared expertise, and collaboration that puts patients at the center.

That’s why we believe the right partnership can help sponsors navigate these complexities and bring new treatments closer to the patients who need them.

Attending ? Anna Taylor and Mo Hashi would love to connect with you to discuss your clinical development challenges and explore how we can move research forward together.

Let's connect at NORD: [email protected]

Your CRO is supposed to take work off your plate. So why does your week look like this?➡️ Chasing updates➡️ Escalating i...
2026-10-15

Your CRO is supposed to take work off your plate. So why does your week look like this?

➡️ Chasing updates
➡️ Escalating issues
➡️ Coordinating teams that should already be aligned
➡️ Writing the fix for a problem you didn’t cause

The work doesn’t go away. It lands on you.

And it costs more than time. You have less room for your own oversight, your team is stretched thin, and in a rare disease study there aren’t many patients or sites to spare.

If managing your has become a second job, the answer probably isn’t more effort. It’s a different model.

If this is your week, message us. Let’s talk about getting your study back on track.

As we celebrate Canadian Thanksgiving, let's appreciate the people, moments, and connections that enrich our lives.Wishi...
2026-10-09

As we celebrate Canadian Thanksgiving, let's appreciate the people, moments, and connections that enrich our lives.

Wishing everyone a beautiful weekend filled with warmth, gratitude, and time spent with those who matter most.

🍁 Happy Thanksgiving! 🍁

It rarely starts as a big failure. After a successful study start, the first-patient-in milestone is achieved. Then resp...
2026-10-08

It rarely starts as a big failure. After a successful study start, the first-patient-in milestone is achieved. Then responsiveness slows, issues surface without solutions, and decisions stall.

Nobody’s quite sure who makes the call, and a team that should work as one feels fragmented and disconnected. Eventually you realize you’re running the study you hired someone else to run.

Here’s a few things we’ve heard:
➡️ “We thought our study would be big enough for them to care”
➡️ “We’re identifying the issues and providing the solutions”
➡️ “We have a 12-person study team, and no one can take accountability”

Sound familiar? Individually, these can look like operational frustrations. Together, they point to something bigger: an operating model that isn't built for a study like yours.

Complex trials need more than processes and resources. They need accountability, responsiveness, and a team that adapts when the study does.

Studies can get back on track. Let’s talk about yours.

2026-08-13

A single study visit rarely involves just the patient.

Time off work. Travel. Childcare. Coordinating schedules. For caregiver-dependent populations, every visit can ripple through an entire household.

And the burden isn’t only in the planning. A delayed flight. Transfer complications. A last-minute change. One unexpected obstacle can quickly turn an already demanding journey into a moment when participation feels like too much.

Behind every study visit is a family trying to make it work.

The Stiris Patient Caregiver Liaison (PCL) Program provides a dedicated, non-clinical point of contact to help patients and families navigate the journey with guidance, support, and continuity.

Not replacing the site. Complementing it—so families feel supported while sites and sponsors maintain visibility.

The people behind the protocol are the reason it works.

Beyond the protocol.
Where science meets the real world.

Every clinical trial is defined by its protocol. Before the first patient is enrolled, investigators, clinical scientist...
2026-08-10

Every clinical trial is defined by its protocol. Before the first patient is enrolled, investigators, clinical scientists, ethics committees, and regulatory authorities review, challenge, and refine it. Every visit and every assessment is carefully considered to protect patients and preserve the integrity of the research.

But no protocol can anticipate every conversation, every concern, or every challenge that unfolds once a study begins. It can't account for the parent coordinating appointments, the caregiver balancing competing responsibilities, or the study coordinator finding solutions to keep a patient engaged.

In rare disease, neuromuscular, and pediatric research, participation extends far beyond the patient. It involves caregivers, families, and research sites working together, often for months or years, to make every visit possible.

That's what this series is about. Over the next four weeks, we'll explore what happens beyond the protocol and why supporting the people who make it possible is essential to engagement, retention, and study success.

Address

2397 Oxford Street West
London, ON
N6K4P1

Opening Hours

Monday 8am - 4:30pm
Tuesday 8am - 4:30pm
Wednesday 8am - 4:30pm
Thursday 8am - 4:30pm
Friday 8am - 4:30pm

Telephone

+15196525327

Alerts

Be the first to know and let us send you an email when Stiris Research Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Stiris Research Inc:

Shortcuts

Share

Nearby businesses